{"id":"https://openalex.org/W2018897037","doi":"https://doi.org/10.1097/00004714-200104000-00015","title":"Comparing Guanfacine and Dextroamphetamine for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder","display_name":"Comparing Guanfacine and Dextroamphetamine for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W2018897037","doi":"https://doi.org/10.1097/00004714-200104000-00015","mag":"2018897037","pmid":"https://pubmed.ncbi.nlm.nih.gov/11270920"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-200104000-00015","doi":"https://doi.org/10.1097/00004714-200104000-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200104000-00015","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Fletcher B. Taylor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Fletcher B. Taylor","raw_affiliation_strings":["Rainier Associates, Tacoma, Washington 98467, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rainier Associates, Tacoma, Washington 98467, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068712457","display_name":"Joan Russo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan Russo","raw_affiliation_strings":["University of Washington, Department of Psychiatry and Behavioral Sciences, Seattle, Washington","University of Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Department of Psychiatry and Behavioral Sciences, Seattle, Washington","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"University of Washington","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.9252,"has_fulltext":false,"cited_by_count":189,"citation_normalized_percentile":{"value":0.96475883,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"21","issue":"2","first_page":"223","last_page":"228"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adult-adhd","display_name":"adult ADHD","score":0.9269999861717224},{"id":"https://openalex.org/keywords/guanfacine","display_name":"guanfacine","score":1.0},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.996999979019165},{"id":"https://openalex.org/keywords/stimulant-medication","display_name":"stimulant medication","score":0.5979999899864197},{"id":"https://openalex.org/keywords/adhd-symptom-reduction","display_name":"ADHD symptom reduction","score":0.7580000162124634},{"id":"https://openalex.org/keywords/stroop-task","display_name":"Stroop task","score":0.7490000128746033},{"id":"https://openalex.org/keywords/controlled-oral-word-association-test","display_name":"Controlled Oral Word Association Test","score":0.8519999980926514},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.3790000081062317},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7250000238418579},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.9049999713897705}],"concepts":[{"id":"https://openalex.org/C2780815205","wikidata":"https://www.wikidata.org/wiki/Q5613599","display_name":"Guanfacine","level":3,"score":0.9750198125839233},{"id":"https://openalex.org/C2776145449","wikidata":"https://www.wikidata.org/wiki/Q1706418","display_name":"Dextroamphetamine","level":4,"score":0.7244365811347961},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6869540214538574},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5616368055343628},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5253997445106506},{"id":"https://openalex.org/C162967406","wikidata":"https://www.wikidata.org/wiki/Q384176","display_name":"Stroop effect","level":3,"score":0.4707014560699463},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.45828336477279663},{"id":"https://openalex.org/C2779356329","wikidata":"https://www.wikidata.org/wiki/Q922625","display_name":"Checklist","level":2,"score":0.44948112964630127},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4415878653526306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3772805333137512},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.30450761318206787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1862783133983612},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.17953377962112427},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.17048802971839905},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.15315371751785278},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C180747234","wikidata":"https://www.wikidata.org/wiki/Q23373","display_name":"Cognitive psychology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011581","descriptor_name":"Psychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016316","descriptor_name":"Guanfacine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-200104000-00015","doi":"https://doi.org/10.1097/00004714-200104000-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200104000-00015","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:11270920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11270920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1860158865","https://openalex.org/W1963735974","https://openalex.org/W1976456194","https://openalex.org/W1982166376","https://openalex.org/W1995533934","https://openalex.org/W2006001020","https://openalex.org/W2007311340","https://openalex.org/W2008388130","https://openalex.org/W2010339047","https://openalex.org/W2028826814","https://openalex.org/W2042348492","https://openalex.org/W2049710132","https://openalex.org/W2061059960","https://openalex.org/W2079590493","https://openalex.org/W2083425457","https://openalex.org/W2088047295","https://openalex.org/W2089649622","https://openalex.org/W2090240371","https://openalex.org/W2113255240","https://openalex.org/W2123822033","https://openalex.org/W2151631661","https://openalex.org/W2162054698","https://openalex.org/W2337823340","https://openalex.org/W2342211618","https://openalex.org/W2501275390"],"related_works":["https://openalex.org/W2416192894","https://openalex.org/W1982166376","https://openalex.org/W2039755273","https://openalex.org/W1846643705","https://openalex.org/W2418067944","https://openalex.org/W2161240002","https://openalex.org/W3160092234","https://openalex.org/W2108178511","https://openalex.org/W7167589043","https://openalex.org/W2034683974"],"abstract_inverted_index":{"The":[0,141,167],"objective":[1],"of":[2,10,17,22,50,72,107,114,170,183],"this":[3],"study":[4,42,194],"was":[5,98,172,185],"to":[6,104],"compare":[7],"the":[8,11,20,53,61,75,84,96,129,155,178],"efficacy":[9,109],"alpha-2a":[12],"agonist":[13],"guanfacine":[14,162,171,184,197],"with":[15,111],"that":[16,196],"dextroamphetamine":[18],"for":[19,34,58,65,134,148,161,204],"treatment":[21,202],"adult":[23,28,205],"attention-deficit/hyperactivity":[24],"disorder":[25],"(ADHD).":[26],"Seventeen":[27],"outpatients":[29],"who":[30],"met":[31],"DSM-IV":[32,54,130],"criteria":[33],"ADHD":[35,47,55,126],"participated":[36],"in":[37],"a":[38,112,200],"double-blind,":[39],"placebo-controlled,":[40],"crossover":[41],"comparing":[43],"drug":[44,97,190],"effects":[45],"on":[46,128],"symptoms.":[48],"Measures":[49],"change":[51],"included":[52,74],"Behavior":[56,132],"Checklist":[57,64,133],"Adults":[59,135],"and":[60,77,88,101,117,177],"Copeland":[62],"Symptom":[63],"Adult":[66,131],"Attention":[67],"Deficit":[68],"Disorders.":[69],"Cognitive":[70],"measures":[71,157],"attention":[73],"Stroop":[76,142],"Controlled":[78],"Oral":[79],"Word":[80],"Association":[81],"Test":[82],"using":[83],"letters":[85],"\"C,\"":[86],"\"F,\"":[87],"\"L\"":[89],"(COWAT,":[90],"CFL":[91],"version).":[92],"For":[93],"each":[94],"trial,":[95],"administered":[99],"daily":[100],"titered":[102],"up":[103],"optimal":[105],"doses":[106],"maximum":[108],"but":[110,154],"minimum":[113],"side":[115,181],"effects,":[116],"then":[118],"data":[119],"were":[120],"collected.":[121],"Both":[122],"drugs":[123,150],"significantly":[124],"reduced":[125],"symptoms":[127],"over":[136],"placebo":[137],"(p":[138,151,164],"<":[139,152,165],"0.05).":[140],"Color":[143],"subscale":[144],"showed":[145,158],"significant":[146,159],"improvement":[147,160],"both":[149],"0.05),":[153],"Color-Word":[156],"only":[163],"0.01).":[166],"average":[168],"dose":[169],"1.10":[173],"(SD":[174],"=":[175],"0.60),":[176],"most":[179],"common":[180],"effect":[182],"fatigue.":[186],"No":[187],"subjects":[188],"discontinued":[189],"trials.":[191],"This":[192],"preliminary":[193],"indicates":[195],"may":[198],"be":[199],"well-tolerated":[201],"option":[203],"ADHD.":[206]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}